Besifloxacin CAS# 141388-76-3 贝西沙星
Besifloxacin is a fourth-generation fluoroquinolone antibiotic. The marketed compound is besifloxacin hydrochloride. It was developed by SSP Co. Ltd., Japan, and designated SS734. SSP licensed U.S. and European rights to SS734 for ophthalmic use to InSite Vision Incorporated (OTCBB: INSV) in 2000. InSite Vision developed an eye drop formulation (ISV-403) and conducted preliminary clinical trials before selling the product and all rights to Bausch & Lomb in 2003.
📌 参考资料/链接：
Process for the preparation of besifloxacin and pharmaceutically acceptable salts thereof Rajadhyaksha, Mangesh Narayan; Nair, Ranjeet; Shrigadi, Nilesh Balkrishna; Panandikar, Aditi Assignee Indoco Remedies Limited, India 2014 Patent Information Sep 26, 2014 IN 2013MU00023 A
Process for the preparation of besifloxacin and pharmaceutically acceptable salts thereof Rajadhyaksha, Mangesh Narayan; Nair, Ranjeet; Shrigadi, Nilesh Balkrishna; Panandikar, Aditi Assignee Indoco Remedies Limited, India 2014 Patent Information Sep 26, 2014 IN 2013MU00023 A
📄 详细内容
CAS No. 141388-76-3 贝西沙星Besifloxacin synthetic routes
Process for the preparation of besifloxacin and pharmaceutically acceptable salts thereof Rajadhyaksha, Mangesh Narayan; Nair, Ranjeet; Shrigadi, Nilesh Balkrishna; Panandikar, Aditi Assignee Indoco Remedies Limited, India 2014 Patent Information Sep 26, 2014 IN 2013MU00023 A
产品链接: CAS No. 141388-76-3 ››
Process for the preparation of besifloxacin and pharmaceutically acceptable salts thereof Rajadhyaksha, Mangesh Narayan; Nair, Ranjeet; Shrigadi, Nilesh Balkrishna; Panandikar, Aditi Assignee Indoco Remedies Limited, India 2014 Patent Information Sep 26, 2014 IN 2013MU00023 A
产品链接: CAS No. 141388-76-3 ››